| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 01/27/2011 | US20110020388 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents |
| 01/27/2011 | US20110020385 COMBINATIONS OF PNEUMOCOCCAL RrgB CLADES |
| 01/27/2011 | US20110020383 Novel genes and proteins of brachyspira hyodysenteriae and uses thereof |
| 01/27/2011 | US20110020380 Human Tumor Necrosis Factor TR18 and Methods Based Thereon |
| 01/27/2011 | US20110020379 Cobalamin Assay |
| 01/27/2011 | US20110020378 Self-assembling peptide nanoparticles useful as vaccines |
| 01/27/2011 | US20110020375 Stromal cell-derived factor-1 polypeptides, polynucleotides, modulators thereof and methods of use |
| 01/27/2011 | US20110020373 Ige directed dna vaccination |
| 01/27/2011 | US20110020369 Engineered anti-tslpr antibodies |
| 01/27/2011 | US20110020367 Methods of Evaluating Transplant Rejection |
| 01/27/2011 | US20110020366 Use of benzophenone derivative or salt thereof and tnf alpha inhibitor in combination and pharmaceutical composition containing the derivative or salt thereof and the inhibitor |
| 01/27/2011 | US20110020355 Treatment and prevention of gardnerella vaginalis infections |
| 01/27/2011 | US20110020352 Endogenous retroviruses up-regulated in prostate cancer |
| 01/27/2011 | US20110020343 Auristatin drug linker conjugates |
| 01/27/2011 | US20110020328 Antibody formulations |
| 01/27/2011 | US20110020324 Compound capable of binding s1p receptor and pharmaceutical use thereof |
| 01/27/2011 | US20110020315 Treatment of inflammatory illnesses with ace2 |
| 01/27/2011 | US20110020309 Ex-vivo priming for generating cytotoxic t lymphocytes specific for non-tumor antigens to treat autoimmune and allergice disease |
| 01/27/2011 | US20110020308 Expression of transgenic t cell receptors in lak-t cells |
| 01/27/2011 | US20110020296 Methods for treating diseases and increasing longevity |
| 01/27/2011 | US20110020295 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 01/27/2011 | US20110020284 Probiotic bifidobacterium strains |
| 01/27/2011 | US20110020283 Probiotic, gram-positive bacteria for the prophylaxis, suppression, or elimination of allergic reactions in humans |
| 01/27/2011 | US20110020279 Rabies cure |
| 01/27/2011 | US20110020274 Mobilization of hematopoietic stem cells |
| 01/27/2011 | US20110020270 Treatment and prophylaxis |
| 01/27/2011 | US20110020269 Methods and compositions for modifying t cell immune responses and inflammation |
| 01/27/2011 | US20110020267 Tweak receptor |
| 01/27/2011 | US20110020266 G-CSF Conjugates |
| 01/27/2011 | US20110020234 Rna interference mediating small rna molecules |
| 01/27/2011 | US20110020226 Particle structures comprising sterols and saponins |
| 01/27/2011 | CA2768810A1 Skin external-preparation composition |
| 01/26/2011 | EP2278013A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2278012A2 Avirulent, immunogenic flavivirus chimeras |
| 01/26/2011 | EP2278004A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 01/26/2011 | EP2277920A2 Inhibitors of complement activation |
| 01/26/2011 | EP2277898A2 Rapamycin analogues |
| 01/26/2011 | EP2277897A1 Streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
| 01/26/2011 | EP2277878A1 Process for production of ethynylthymidine compound using 5-methyluridine as starting raw material |
| 01/26/2011 | EP2277876A1 Substituted pyrimidines for the treatment of cancer |
| 01/26/2011 | EP2277865A1 Phenyl-substituted 6-ring nitrogen-heterocycles as microtubule polymerisation inhibitors |
| 01/26/2011 | EP2277861A1 Cyclic amine-1-carboxylic acid ester derivative and pharmaceutical composition containing the same |
| 01/26/2011 | EP2277857A2 New crystalline form V of agomelatine, method of preparing same and pharmaceutical compositions containing same |
| 01/26/2011 | EP2277595A2 Compounds for immunopotentiation |
| 01/26/2011 | EP2277541A1 Multivalent vaccine composition |
| 01/26/2011 | EP2277535A2 Vaccine |
| 01/26/2011 | EP2277526A1 Pharmaceutical composition with tetrahydroisohumulone |
| 01/26/2011 | EP2276774A2 Therapeutic substances that modulate genome methylation |
| 01/26/2011 | EP2276747A1 Sulfonamides as zap-70 inhibitors |
| 01/26/2011 | EP2276503A2 Citrullinated cytokines |
| 01/26/2011 | EP2125804B1 5-phenyl-6-pyridin-4-yl-1,3-dihydro-2h-imidazo[4,5-b]pyridin-2-one derivatives useful as a2b adenosine receptor antagonists |
| 01/26/2011 | EP2004597B1 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 01/26/2011 | EP1817337B1 Therapeutic peptides comprising sequences derived from cdr2 or cdr3 of trem-1 and uses thereof to inhibit sepsis |
| 01/26/2011 | EP1725261B1 Use of agonists and antagonists of interleukin-33 (il-33) |
| 01/26/2011 | EP1496892B1 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/26/2011 | EP1289545B1 Synthetic vaccine for tick control |
| 01/26/2011 | EP0946725B1 Receptor activator of nf-kappa b, receptor is member of tnf receptor superfamily |
| 01/26/2011 | CN101959889A Heterocyclic compounds as inhibitors of CXCR2 |
| 01/26/2011 | CN101959845A Process for the preparation of 2-amino-2- [2- (4-C3-C21-alkyl-phenyl)ethyl] propane-1, 3-diols |
| 01/26/2011 | CN101959524A 抗过敏剂 Antiallergic agent |
| 01/26/2011 | CN101955976A Methods and immune modulatory nucleic acid compositions for preventing and treating disease |
| 01/26/2011 | CN101955547A Method for comprehensively extracting changium smyrnioide polysaccharides and amino acid |
| 01/26/2011 | CN101955524A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 01/26/2011 | CN101955505A Novel immune suppressor and composition thereof |
| 01/26/2011 | CN101954095A Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells |
| 01/26/2011 | CN101954071A Use of ulinastatin in preparation of medicament for treating systemic lupus erythematosus and medicinal composition of ulinastatin |
| 01/26/2011 | CN101954070A Preparation method of composition of nano SOD and vegetable drugs and health-care food or extracts thereof |
| 01/26/2011 | CN101953987A Chinese medicinal composition for improving chicken immunity and preparation method thereof |
| 01/26/2011 | CN101953949A Chinese medicinal composition for treating allergic rhinitis |
| 01/26/2011 | CN101953947A Method for preparing composite propolis health care product |
| 01/26/2011 | CN101953936A Traditional Chinese medicine preparation for treating immune thrombocytopenia and preparation method thereof |
| 01/26/2011 | CN101953927A External Chinese medicinal liniment for treating urticaria |
| 01/26/2011 | CN101953912A Rose donkey-hide gelatin jelly and preparation method thereof |
| 01/26/2011 | CN101953902A Pharmaceutical composition for postoperative recovery of chemoradiation |
| 01/26/2011 | CN101953896A Health-care health-preserving Chinese medicament capable of eliminating sexual sub-health of human body and preparation method thereof |
| 01/26/2011 | CN101953857A Compound fermented cordyceps sinensis bacterium powder (paecilomyces hepiali Cs-4 bacterium powder) composite medicine |
| 01/26/2011 | CN101953855A Preparation method and application for lactobacillus cell wall lysate |
| 01/26/2011 | CN101953853A Preparation method of purified and deleaded propolis powder and propolis product |
| 01/26/2011 | CN101953807A Mycophenolate mofetil lyophilized powder injection for injection and preparation method thereof |
| 01/26/2011 | CN101953798A Spray drying sustained-release liquid crystal nano particles containing paeonol and preparation thereof |
| 01/26/2011 | CN101669961B Method for producing Chinese-western compound preparation for preventing and treating animal synthetic respiratory diseases |
| 01/26/2011 | CN101623315B Antibacterial immune double-effect compound Chinese herb for skin ulcerative syndrome of apostichopus japonicus |
| 01/26/2011 | CN101524393B Preparation method of gypenoside |
| 01/26/2011 | CN101492672B Sulpho-oligodeoxynucleotide with immune stimulation activity and uses thereof |
| 01/26/2011 | CN101454439B Method for culture of lactic acid bacterium having high immunomodulating activity |
| 01/26/2011 | CN101433609B Use of pharmaceutical composition in preparing medicament for preventing and treating allergic diseases |
| 01/26/2011 | CN101396531B Traditional Chinese medicine for treating allergic purpura |
| 01/26/2011 | CN101205542B Construction method of shRNA expression carrier for inhibiting core1 beta1-3 galactosyltransferase and use thereof |
| 01/26/2011 | CN101084190B 2,3,4,9-tetrahydro-1H-carbazole derivatives as CRTH2 receptor antagonists |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/26/2011 | CN101007082B A health mongolian veterinary drug |
| 01/25/2011 | US7875728 Hydrazonopyrazole derivatives and their use as therapeutics |
| 01/25/2011 | US7875712 inhibitors of apoptosis and IL-1 beta secretion; mediate cell apoptosis and inflammation; good cell penetration and pharmacokinetic properties; [3S/R(2S)]3-[2-(Carbazol-9-yl-2-oxo-ethyl)-pentanoylamino]-5-fluoro-4-oxo-pentanoic acid |
| 01/25/2011 | US7875703 Comprises nucleotide sequences coding antibody receptor for treating autoimmune and immunological diseases |
| 01/25/2011 | US7875677 Micellar drug delivery systems for hydrophobic drugs |
| 01/25/2011 | US7875611 Ion channel modulating compounds and uses thereof |
| 01/25/2011 | US7875301 comprising Cucurbita moschata, Carthamus tinctorius, Plantago asiatica and Lonicera japonica; treating neutropenia and aplastic anemia |
| 01/25/2011 | US7875298 Kit; leaves of Melissa Officinalis, Eleutherococcus senticosus; Avena sativa, Ballota Nigra, roots of Glycyrrhiza glabra/gan cao, roots of Uncaria Tomentosa; lupus, multiple sclerosis, rheumatoid arthritis, rheumatism, osteoporosis, asthma |
| 01/25/2011 | US7875279 intermediates of the mevalonate-independent pathway for isoprenoid biosynthesis are enriched by deleting or inactivating genes; asthma, morbus Crohn, colitis ulcerosa, multiple sclerosis and chronic bronchitis and immune and auto-immune diseases and allergies and bone diseases and osteoporosis |
| 01/25/2011 | CA2635963C Human monoclonal antibody against a costimulatory signal transduction molecule ailim and pharmaceutical use thereof |